GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medrx Co Ltd (TSE:4586) » Definitions » Institutional Ownership

Medrx Co (TSE:4586) Institutional Ownership : 0.09% (As of Sep. 25, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Medrx Co Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Medrx Co's institutional ownership is 0.09%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Medrx Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Medrx Co's Float Percentage Of Total Shares Outstanding is 0.00%.


Medrx Co Institutional Ownership Historical Data

The historical data trend for Medrx Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medrx Co Institutional Ownership Chart

Medrx Co Historical Data

The historical data trend for Medrx Co can be seen below:

2021-01-31 2021-02-28 2021-03-31 2021-04-30 2021-05-31 2021-06-30 2021-07-31 2021-08-31 2021-09-30 2021-10-31
Institutional Ownership 0.11 0.11 0.11 0.11 0.11 0.10 0.10 0.10 0.09 0.09

Medrx Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Medrx Co Business Description

Traded in Other Exchanges
N/A
Address
431-7 Nishiyama, Higashikagawa, Kagawa, JPN, 769-2712
Medrx Co Ltd is a pharmaceutical drug development company founded in January, 2002. The Company engaged in the research and development of pharmaceutical products utilizing the pharmaceutical formulation technology based on ionic liquid transdermal system. The Company develops new pharmaceutical candidates and licenses other companies to produce the pharmaceuticals after clinical trials. Its main products include analgesic patches for anti-inflammatory and pain relief.

Medrx Co Headlines

No Headlines